Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    SGI-110 hepatocellular carcinoma
Show Display Options
Rank Status Study
1 Recruiting SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: SGI-110

Indicates status has not been verified in more than two years